83 related articles for article (PubMed ID: 23675579)
1. A new dimension for cell identification by FTIR spectroscopy: depth profiling in attenuated total reflection.
Gaigneaux A; Goormaghtigh E
Analyst; 2013 Jul; 138(14):4070-5. PubMed ID: 23675579
[TBL] [Abstract][Full Text] [Related]
2. Rapid recognition of drug-resistance/sensitivity in leukemic cells by Fourier transform infrared microspectroscopy and unsupervised hierarchical cluster analysis.
Bellisola G; Cinque G; Vezzalini M; Moratti E; Silvestri G; Redaelli S; Gambacorti Passerini C; Wehbe K; Sorio C
Analyst; 2013 Jul; 138(14):3934-45. PubMed ID: 23323262
[TBL] [Abstract][Full Text] [Related]
3. Tracking infrared signatures of drugs in cancer cells by Fourier transform microspectroscopy.
Bellisola G; Della Peruta M; Vezzalini M; Moratti E; Vaccari L; Birarda G; Piccinini M; Cinque G; Sorio C
Analyst; 2010 Dec; 135(12):3077-86. PubMed ID: 20931110
[TBL] [Abstract][Full Text] [Related]
4. Cell discrimination by attenuated total reflection-Fourier transform infrared spectroscopy: the impact of preprocessing of spectra.
Gaigneaux A; Ruysschaert JM; Goormaghtigh E
Appl Spectrosc; 2006 Sep; 60(9):1022-8. PubMed ID: 17002828
[TBL] [Abstract][Full Text] [Related]
5. Combined Fourier transform infrared and Raman spectroscopic approach for identification of multidrug resistance phenotype in cancer cell lines.
Krishna CM; Kegelaer G; Adt I; Rubin S; Kartha VB; Manfait M; Sockalingum GD
Biopolymers; 2006 Aug; 82(5):462-70. PubMed ID: 16493658
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructural appraisal of the multidrug resistance in K562 and LR73 cell lines from Fourier transform infrared spectroscopy.
Le Gal JM; Morjani H; Manfait M
Cancer Res; 1993 Aug; 53(16):3681-6. PubMed ID: 8339276
[TBL] [Abstract][Full Text] [Related]
7. Infrared spectroscopy as a tool for discrimination between sensitive and multiresistant K562 cells.
Gaigneaux A; Ruysschaert JM; Goormaghtigh E
Eur J Biochem; 2002 Apr; 269(7):1968-73. PubMed ID: 11952799
[TBL] [Abstract][Full Text] [Related]
8. Micro-Attenuated Total Reflection Fourier Transform Infrared (Micro ATR FT-IR) Spectroscopic Imaging with Variable Angles of Incidence.
Wrobel TP; Vichi A; Baranska M; Kazarian SG
Appl Spectrosc; 2015 Oct; 69(10):1170-4. PubMed ID: 26449810
[TBL] [Abstract][Full Text] [Related]
9. Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair.
Majsterek I; Sliwinski T; Poplawski T; Pytel D; Kowalski M; Slupianek A; Skorski T; Blasiak J
Mutat Res; 2006 Jan; 603(1):74-82. PubMed ID: 16388976
[TBL] [Abstract][Full Text] [Related]
10. Imatinib resistance in multidrug-resistant K562 human leukemic cells.
Assef Y; Rubio F; Coló G; del Mónaco S; Costas MA; Kotsias BA
Leuk Res; 2009 May; 33(5):710-6. PubMed ID: 18977528
[TBL] [Abstract][Full Text] [Related]
11. Attenuated total reflection Fourier transform infrared (ATR-FTIR) spectroscopy of a single endothelial cell.
Wrobel TP; Marzec KM; Majzner K; Kochan K; Bartus M; Chlopicki S; Baranska M
Analyst; 2012 Sep; 137(18):4135-9. PubMed ID: 22854681
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of dasatinib- and imatinib-resistant chronic myelogenous leukemia cells.
Okabe S; Tauchi T; Ohyashiki K
Clin Cancer Res; 2008 Oct; 14(19):6181-6. PubMed ID: 18829496
[TBL] [Abstract][Full Text] [Related]
13. Cotreatment with vorinostat (suberoylanilide hydroxamic acid) enhances activity of dasatinib (BMS-354825) against imatinib mesylate-sensitive or imatinib mesylate-resistant chronic myelogenous leukemia cells.
Fiskus W; Pranpat M; Balasis M; Bali P; Estrella V; Kumaraswamy S; Rao R; Rocha K; Herger B; Lee F; Richon V; Bhalla K
Clin Cancer Res; 2006 Oct; 12(19):5869-78. PubMed ID: 17020995
[TBL] [Abstract][Full Text] [Related]
14. Discrimination of a transformation phenotype in Syrian golden hamster embryo (SHE) cells using ATR-FTIR spectroscopy.
Walsh MJ; Bruce SW; Pant K; Carmichael PL; Scott AD; Martin FL
Toxicology; 2009 Apr; 258(1):33-8. PubMed ID: 19167452
[TBL] [Abstract][Full Text] [Related]
15. Conformational changes in membrane proteins of multidrug-resistant K562 and primary rat hepatocyte cultures as studied by Fourier transform infrared spectroscopy.
Le Gal JM; Morjani H; Fardel O; Guillouzo A; Manfait M
Anticancer Res; 1994; 14(4A):1541-8. PubMed ID: 7979183
[TBL] [Abstract][Full Text] [Related]
16. Discrimination of single-porin Escherichia (E.) coli mutants by ATR and transmission mode FTIR spectroscopy.
Saraiva RG; Lopes JA; Machado J; Gameiro P; Feio MJ
J Biophotonics; 2014 Jun; 7(6):392-400. PubMed ID: 23184354
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin.
Nimmanapalli R; O'Bryan E; Huang M; Bali P; Burnette PK; Loughran T; Tepperberg J; Jove R; Bhalla K
Cancer Res; 2002 Oct; 62(20):5761-9. PubMed ID: 12384536
[TBL] [Abstract][Full Text] [Related]
18. Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells.
Liao HF; Su YC; Zheng ZY; Jhih Cai C; Hou MH; Chao KS; Chen YJ
Biomed Pharmacother; 2012 Jul; 66(5):378-83. PubMed ID: 22397755
[TBL] [Abstract][Full Text] [Related]
19. Bcr-Abl-independent imatinib-resistant K562 cells show aberrant protein acetylation and increased sensitivity to histone deacetylase inhibitors.
Lee SM; Bae JH; Kim MJ; Lee HS; Lee MK; Chung BS; Kim DW; Kang CD; Kim SH
J Pharmacol Exp Ther; 2007 Sep; 322(3):1084-92. PubMed ID: 17569822
[TBL] [Abstract][Full Text] [Related]
20. Assay for determination of daunorubicin in cancer cells with multidrug resistance phenotype.
Krumpochova P; Kocurova A; Dolezel P; Mlejnek P
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(21):1875-80. PubMed ID: 21641880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
